Evidence map›Paper›PMID 36012350›Full record

ArticleInternational journal of molecular sciences2022

Feature Selection and Molecular Classification of Cancer Phenotypes: A Comparative Study.

Luca Zanella, Pierantonio Facco, Fabrizio Bezzo, Elisa Cimetta

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Machine learning used to study risk factors for chronic diseases: A scoping review.Canadian journal of public health = Revue canadienne de sante publique · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Luca ZanellaDepartment of Industrial Engineering (DII), University of Padova, 35131 Padova, Italy.
Pierantonio FaccoDepartment of Industrial Engineering (DII), University of Padova, 35131 Padova, Italy.ORCID 0000-0001-8383-6783
Fabrizio BezzoDepartment of Industrial Engineering (DII), University of Padova, 35131 Padova, Italy.ORCID 0000-0003-1561-0584
Elisa CimettaDepartment of Industrial Engineering (DII), University of Padova, 35131 Padova, Italy.ORCID 0000-0002-8632-3999

Funding

European Research Council ERC-StG UERI17
6 · The paper itself

Abstract

The classification of high dimensional gene expression data is key to the development of effective diagnostic and prognostic tools. Feature selection involves finding the best subset with the highest power in predicting class labels. Here, we conducted a comparative study focused on different combinations of feature selectors (Chi-Squared, mRMR, Relief-F, and Genetic Algorithms) and classification learning algorithms (Random Forests, PLS-DA, SVM, Regularized Logistic/Multinomial Regression, and kNN) to identify those with the best predictive capacity. The performance of each combination is evaluated through an empirical study on three benchmark cancer-related microarray datasets. Our results first suggest that the quality of the data relevant to the target classes is key for the successful classification of cancer phenotypes. We also proved that, for a given classification learning algorithm and dataset, all filters have a similar performance. Interestingly, filters achieve comparable or even better results with respect to the GA-based wrappers, while also being easier and faster to implement. Taken together, our findings suggest that simple, well-established feature selectors in combination with optimized classifiers guarantee good performances, with no need for complicated and computationally demanding methodologies.

Indexed as

AlgorithmsNeoplasmsHumansLogistic ModelsMicroarray AnalysisPhenotypeSupport Vector Machinecancerclassificationfeature selectiongene expressionlearning algorithm

Identifiers

PMID36012350
PMCPMC9408964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.